Author

Olga M. Kudryashova

Federal Center of Brain Research and NeurotechnologiesORCID 0000-0003-3320-7764Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexander BagaeviD· 1 shared Amanda F. CasheniD· 1 shared Brad S. KahliD· 1 shared Catrina C. FronickiD· 1 shared Cody A. RamireziD· 1 shared Daria Yu. TravnikovaiD· 1 shared David A. Russler‐GermainiD· 1 shared Elena Ocheredko· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alexander BagaevORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 2, 2024

Downregulation of Gankyrin/PSMD10 affects cancer cell growth and proliferation in glioblastoma: in vitro and in vivo study

Daria Yu. Travnikova, Vera S. Shashkovskaya, Maria Kordyukova…·Tatiana O. Abakumova

This study shows that downregulating Gankyrin/PSMD10 in glioblastoma cells reduces proliferation, increases apoptosis, and enhances chemotherapy effectiveness in vitro and in vivo.

DOI 10.1101/2024.12.02.626412

mousehuman

𝕏 PostBluesky

Genetic & Genomic MedicineBlood AdvancesPeer-reviewedMay 7, 2024

Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma

Cody A. Ramirez, Michelle Becker‐Hapak, Kartik Singhal…·Todd A. Fehniger

This study identifies high-quality neoantigens in follicular lymphoma patients using WES and RNA-Seq, and initiates a clinical trial of personalized neoantigen vaccines combined with PD-1 blockade.

19 citations

humanwhole-exome sequencing

𝕏 PostBluesky